Evidence mapPaperPMID 28436051Full record

ArticleBiomedical chromatography : BMC2017

A novel mass spectrometry-based method for simultaneous determination of asymmetric and symmetric dimethylarginine, l-arginine and l-citrulline optimized for LC-MS-TOF and LC-MS/MS.

Jerzy Wiśniewski, Mariusz G Fleszar, Joanna Piechowicz, Małgorzata Krzystek-Korpacka, Angelika Chachaj, Andrzej Szuba, Katarzyna Lorenc-Kukula, Leszek Masłowski, Wojciech Witkiewicz, Andrzej Gamian

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Biomedical chromatography : BMC, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT03398356. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03398356 phase4completed

The Assessment of the Effect of Metformin and Its Serum Concentration on the Concentration of Substances Associated With the Production of Nitric Oxide in Patients With Impaired Carbohydrate Metabolism

Ran2017Enrolled47Registered outcomes6Posted comparisons0ConditionsImpaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT), PrediabetesArmsMetformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. LC-MS analysis ofRSC advances · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Jerzy WiśniewskiDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0003-2831-7643
Mariusz G FleszarDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Joanna PiechowiczDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Małgorzata Krzystek-KorpackaDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Angelika ChachajDepartment of Angiology, Wroclaw Medical University, Wroclaw, Poland.
Andrzej SzubaDepartment of Angiology, Wroclaw Medical University, Wroclaw, Poland.
Katarzyna Lorenc-KukulaShimadzu Center For Advanced Analytical Chemistry, The University of Texas at Arlington, TX, USA.
Leszek MasłowskiDepartment of Vascular Surgery, Regional Specialist Hospital, Wroclaw, Poland.
Wojciech WitkiewiczDepartment of Surgical Oncology, Regional Specialist Hospital, Wroclaw, Poland.
Andrzej GamianDepartment of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.
Wroclaw Medical University · PLŁukasiewicz Research Network – PORT Polish Center for Technology Development · PLMilitary Hospital · PKThe University of Texas at Arlington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is a regulatory molecule involved in many biological processes. NO is produced by nitric oxide synthase by conversion of l-arginine to l-citrulline. l-Arginine methylated derivatives, asymmetric and symmetric dimethylarginines (asymmetric dimethylarginine, ADMA, and symmetric dimethylarginine, SDMA), regulate l-arginine availability and the activity of nitric oxide synthase. As such, they have been frequently investigated as potential biomarkers in pathologies associated with dysfunctions in NO synthesis. Here, we present a new multistep analytical methodology based on liquid chromatography combined with mass spectrometry for the accurate identification of l-arginine, l-citrulline, ADMA and SDMA. Compounds are measured as stable 2,3,4,5,6-pentafluorobenzoyl chloride derivatives, which allows for simultaneous analysis of all compounds through chromatographic separation of ADMA and SDMA using a reverse-phase column. Serum aliquots (100 μL) were spiked with isotope-labeled internal standards and sodium carbonate buffer. The derivatization process was carried out at 25°C for 10 minu using pentafluorobenzoyl chloride as derivatization reagent. Calibration demonstrated good linearity (R

Indexed as

ArginineChromatography, LiquidCitrullineHumansLimit of DetectionLinear ModelsNitric OxideReproducibility of ResultsTandem Mass SpectrometryArginineCitrullineNitric OxideADMAamino acids derivatizationelectrospray ionizationliquid chromatography-mass spectrometrynitric oxidequantitative analysis

Identifiers

PMID28436051
OpenAlexW2608573425

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.